| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.045 | 0.4 |